Surgical navigation systems market was valued at $628 million in 2015, and is projected to reach $963 million by 2022, growing at a CAGR of 6.3% from 2016 to 2022, according to a new report Optical navigation systems segment is expected to grow at the highest growth rate during the forecast period, owing to benefits such as minimum radiation exposure and preciseness & accuracy during complex surgeries.
The major factors that drive the growth of this market include rise in adoption of minimal invasive surgeries, improvement in healthcare infrastructure in emerging economies, numerous technological advancements, increase in incidence of ENT and neurosurgery-related disorders, and growth in knee replacement surgeries globally. However, high cost of these systems and stringent FDA rules are the major barriers that restrain the market growth.
ENT navigation system segment is anticipated to grow at the highest CAGR, attributed to the increase in prevalence of ENT-related disorders and rise in adoption of surgical navigation systems among ambulatory settings. Neurosurgery navigation system held the largest market share in 2015, accounting for more than two-fifths share, owing to high adoption rate of navigation systems in neurosurgical procedures.
- Medtronic plc (Ireland)
- Stryker Corporation (U.S.)
- Brainlab AG (Germany)
- B. Braun Melsungen AG (Germany)
- Scopis GmbH (Germany)
- Fiagon AG (Germany)
- Karl Storz GmbH & Co. KG (Germany)
- Amplitude Surgical (France)
- Zimmer Biomet Holdings
Siemens Healthineers (Germany)
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Surgical Navigation Systems Market, By Technology
Chapter 5 Surgical Navigation Systems Market, By Application
Chapter 6 Surgical Navigation Systems Market, By End User
Chapter 7 Surgical Navigation Systems Market, By Geography
Chapter 8 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/9tthrh/surgical